Search
Now showing items 1-6 of 6
Prevalence of drug-drug interactions of warfarin prescriptions in South Africa
(2012)
Background: Warfarin is an anticoagulant that is used for the prophylactic and therapeutic treatment for a wide range of thrombo-embolic disorders. The prescribing and monitoring of warfarin therapy is challenging due to ...
Prescribing patterns of asthma treatment in the private healthcare sector of South Africa
(2013)
Asthma is a chronic disease of the airways and affects many people regardless of their age, gender, race and socioeconomic status. Since asthma is recognised as one of the major causes of morbidity and mortality in people ...
Clozapine usage in a public sector psychiatric hospital in the Nelson Mandela Metropole
(2013)
About 30.00% of schizophrenic patients fail to respond to conventional antipsychotics. Clozapine shows superior efficacy, for both the positive and negative symptoms of schizophrenia, over conventional antipsychotics. The ...
Influence of blood culture results on antimicrobial prescribing in a private hospital in North West, South Africa
(North-West University (South-Africa), 2020)
Blood culture laboratory testing and the results thereof can be seen as a cornerstone for optimised antimicrobial treatment and has the power to influence and change how effectively patients are treated with antibiotics, ...
Burden of rheumatoid arthritis in the private health sector : medicine cost and comorbidities
(North-West University, 2018)
The purpose of the study was to determine the prevalence of rheumatoid arthritis (RA) and associated comorbidities, as well as to investigate antirheumatic prescribing patterns, direct medicine treatment cost and the impact ...
Factors associated with prescribing and dispensing of schizophrenia treatment in the private health sector of South Africa
(North-West University (South Africa) , Potchefstroom Campus, 2015)
The aim of this study was to determine the prevalence, medicine prescribing patterns and maximum potential savings through generic substitution in direct treatment costs associated with schizophrenia in the private health ...